Upgrade to SI Premium - Free Trial

Vertex (VRTX) Q1 Quiet, But Reimbursement Commentary 'Encouraging'; Leerink Says; PT Up to $150

April 30, 2015 6:18 AM
Leerink Partners analyst Howard Liang reiterated an Outperform rating and boosted his price target on Vertex (NASDAQ: VRTX) to $150.00 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS View Analyst PT Change

Next Articles